Tender Loving Care for Recurrent Pregnancy Loss
Launched by WALTER REED NATIONAL MILITARY MEDICAL CENTER · Dec 13, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Tender Loving Care for Recurrent Pregnancy Loss," is exploring whether a special weekly messaging program can help women who have experienced multiple miscarriages. The study aims to see if these supportive messages can lead to more successful pregnancies (live births) and improve the overall well-being of participants, including reducing feelings of depression.
To be eligible for the trial, participants must be women who are pregnant (up to 10 weeks along) and have had at least two previous pregnancy losses. They should also be able to communicate in English. Throughout the study, participants will receive weekly messages offering prenatal advice and support and will complete surveys about their quality of life. This trial is currently recruiting participants, and it provides an opportunity for women facing similar challenges to receive additional support during their pregnancy journey.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant individuals receiving their prenatal care at WRNMMC
- • Able to speak and understand English
- • Less than or equal to 10+0 weeks gestation by last menstrual period (LMP) or dating ultrasound at the time of enrollment
- • At least two prior pregnancy losses. Pregnancy losses must be confirmed with laboratory criteria confirming a positive pregnancy test in the military electronic medical record with subsequent resolution (resolution may be reported by patient), or with ultrasound criteria demonstrating an intrauterine gestational sac with subsequent resolution (resolution may be reported by patient).
- Exclusion Criteria:
- • Age less than 18 years and older than 44 at time of enrollment
- • Unable to speak or understand English
- • Current smoker or tobacco use within 30 days
- • History of uterine anomaly, coagulopathy, balanced translocation, endometrial polyps, submucosal fibroids, pathology confirmed acute or chronic endometritis, hydrosalpinx, history of Asherman syndrome, poorly controlled endocrinopathies, HIV infection
- • History of gonadotoxic therapy or cancerous condition of the female reproductive tract
- • Suspicion for or confirmation of an ectopic pregnancy
About Walter Reed National Military Medical Center
Walter Reed National Military Medical Center (WRNMMC) is a premier medical facility dedicated to providing comprehensive healthcare services to military personnel, their families, and veterans. As a leader in clinical research and trials, WRNMMC focuses on advancing medical knowledge and improving patient outcomes through innovative studies in various fields, including trauma care, infectious diseases, and rehabilitation. The center is committed to upholding the highest ethical standards in research while fostering collaboration among military and civilian healthcare professionals. Its mission is to enhance the health and well-being of service members and the broader community through cutting-edge research and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Patients applied
Trial Officials
David Boedeker, DO
Principal Investigator
Walter Reed National Military Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported